The results indicated that inhibition of the PI3K/Akt/NF-κB pathway by LY294002 (Akt inhibitor) and PDTC (NF-κB inhibitor) potentiated the suppressive effect of ABCE1 down-regulation on TMZ resistance in glioma cells. Here, ABCE1 is linked to central nervous system cancer.